203 related articles for article (PubMed ID: 16215396)
1. The use of topical nonabsorbable gastrointestinal antifungal prophylaxis to prevent fungal infections in critically ill immunocompetent patients: a meta-analysis.
Ho KM; Rochford SA; John G
Crit Care Med; 2005 Oct; 33(10):2383-92. PubMed ID: 16215396
[TBL] [Abstract][Full Text] [Related]
2. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
3. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
Playford EG; Webster AC; Sorrell TC; Craig JC
J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
[TBL] [Abstract][Full Text] [Related]
4. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Playford EG; Webster AC; Sorrell TC; Craig JC
Cochrane Database Syst Rev; 2006 Jan; (1):CD004920. PubMed ID: 16437504
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Austin N; Darlow BA; McGuire W
Cochrane Database Syst Rev; 2009 Oct; (4):CD003478. PubMed ID: 19821309
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants.
Clerihew L; Austin N; McGuire W
Cochrane Database Syst Rev; 2007 Oct; (4):CD003850. PubMed ID: 17943803
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis in immunocompromised hosts.
Reents S; Goodwin SD; Singh V
Ann Pharmacother; 1993 Jan; 27(1):53-60. PubMed ID: 8431623
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
9. The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis.
Ho KM; Lipman J; Dobb GJ; Webb SA
Crit Care; 2005; 9(6):R710-7. PubMed ID: 16280069
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.
Shorr AF; Chung K; Jackson WL; Waterman PE; Kollef MH
Crit Care Med; 2005 Sep; 33(9):1928-35; quiz 1936. PubMed ID: 16148461
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.
Harrison D; Muskett H; Harvey S; Grieve R; Shahin J; Patel K; Sadique Z; Allen E; Dybowski R; Jit M; Edgeworth J; Kibbler C; Barnes R; Soni N; Rowan K
Health Technol Assess; 2013 Feb; 17(3):1-156. PubMed ID: 23369845
[TBL] [Abstract][Full Text] [Related]
12. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
[TBL] [Abstract][Full Text] [Related]
13. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis.
Cruciani M; Mengoli C; Malena M; Bosco O; Serpelloni G; Grossi P
Liver Transpl; 2006 May; 12(5):850-8. PubMed ID: 16628697
[TBL] [Abstract][Full Text] [Related]
14. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
[TBL] [Abstract][Full Text] [Related]
15. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.
Robenshtok E; Gafter-Gvili A; Goldberg E; Weinberger M; Yeshurun M; Leibovici L; Paul M
J Clin Oncol; 2007 Dec; 25(34):5471-89. PubMed ID: 17909198
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic prophylaxis for preventing burn wound infection.
Barajas-Nava LA; López-Alcalde J; Roqué i Figuls M; Solà I; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Jun; (6):CD008738. PubMed ID: 23740764
[TBL] [Abstract][Full Text] [Related]
17. How to select an antifungal agent in critically ill patients.
Dimopoulos G; Antonopoulou A; Armaganidis A; Vincent JL
J Crit Care; 2013 Oct; 28(5):717-27. PubMed ID: 24018296
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials.
D'Amico R; Pifferi S; Leonetti C; Torri V; Tinazzi A; Liberati A
BMJ; 1998 Apr; 316(7140):1275-85. PubMed ID: 9554897
[TBL] [Abstract][Full Text] [Related]
19. Nystatin prophylaxis and treatment in severely immunodepressed patients.
Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2002; (4):CD002033. PubMed ID: 12519566
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Austin NC; Darlow B
Cochrane Database Syst Rev; 2004; (1):CD003478. PubMed ID: 14974017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
